Medicare Enrolled

Dr. Ana Garza Avila, M.D., MSC

Pulmonary Disease · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4458 MEDICAL DR STE 505, San Antonio, TX 78229
2106907400
In practice since 2008 (17 years)
NPI: 1871738385 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garza Avila from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garza Avila? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garza Avila

Dr. Ana Garza Avila is a pulmonary disease in San Antonio, TX, with 17 years in practice. Based on federal Medicare data, Dr. Garza Avila performed 1,419 Medicare services across 777 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garza Avila received a total of $4,804 from 21 pharmaceutical and/or device companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garza Avila is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 36% volume in TX$ $4,804 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,419
Medicare services
Top 36% in TX for pulmonary disease
777
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~83 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity480$91$255
Critical care, first 30-74 min414$160$668
Office visit, established patient (20-29 min)122$63$174
Office visit, established patient (30-39 min)103$88$259
Test to examine how well the lungs exchange gases71$40$128
Test to measure expiratory airflow and volume57$20$85
Hospital follow-up visit, moderate complexity34$61$177
Initial hospital admission, high complexity32$133$496
Test to measure expiratory airflow and volume changes before and after medication administration25$27$143
Test to determine lung volumes using sensors22$39$124
Emergent insertion of breathing tube into windpipe using an endoscope16$107$275
Irrigation and suction of lung airways to obtain cells using an endoscope15$94$340
Initial hospital admission, moderate complexity15$95$335
New patient office visit (30-44 min)13$85$260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,804
Total received (2018-2024)
Avg $686/year across 7 years
Top 34% in TX for pulmonary disease
21
Companies
169
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,804 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$692
2023
$495
2022
$2,278
2021
$590
2020
$186
2019
$176
2018
$388

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,336
AstraZeneca Pharmaceuticals LP
$632
GlaxoSmithKline, LLC.
$612
Boehringer Ingelheim Pharmaceuticals, Inc.
$472
Janssen Pharmaceuticals, Inc
$327
Mylan Specialty L.P.
$325
Regeneron Healthcare Solutions, Inc.
$191
GENZYME CORPORATION
$191
Inari Medical, Inc.
$123
EKOS Corporation
$98
Insmed, Inc.
$73
Grifols USA, LLC
$60
Genentech USA, Inc.
$59
Advanced Respiratory, Inc
$57
Philips Electronics North America Corporation
$53
United Therapeutics Corporation
$41
Bayer HealthCare Pharmaceuticals Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$38
Baxter Healthcare
$37
JAZZ PHARMACEUTICALS INC.
$22
Mallinckrodt Hospital Products Inc.
$20
Top 3 companies account for 53.7% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO ELLIPTA · AREXVY · Adempas · AngioJet Ultra 5000A · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · Dymista · EKOSONIC · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · General - Thrombectomy · Hillrom - Life 2000 Ventilation System · NUCALA · OFEV · Prolastin-C · Prolastin-C Liquid · S · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · XARELTO · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $339 per 100 Medicare services performed
Looking for a pulmonary disease in San Antonio?
Compare pulmonary diseases in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
73
Per 100K population
3.6
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garza Avila is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garza Avila experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Garza Avila performed 480 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garza Avila receive payments from pharmaceutical companies?
Yes. Dr. Garza Avila received a total of $4,804 from 21 companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garza Avila's costs compare to other pulmonary diseases in San Antonio?
Dr. Garza Avila's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garza Avila) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →